Allergies, obesity, other risk factors and survival from pancreatic cancer

International Journal of Cancer

Volumn 127, Issue 10, 2010, Pages 2412-2419

  Olson, Sara H ^a   Chou, Joanne F ^a   Ludwig, Emmy ^a   O'Reilly, Eileen ^a   Allen, Peter J ^a   Jarnagin, William R ^a   Bayuga, Sharon ^a   Simon, Jennifer ^a   Gonen, Mithat ^a   Reisacher, William R ^b   Kurtz, Robert C ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

allergies; BMI; pancreatic cancer; survival

Indexed keywords

ADULT; ALLERGY; ARTICLE; BODY MASS; CANCER SURVIVAL; CARCINOGENESIS; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE DURATION; FAMILY HISTORY; FEMALE; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; OVERALL SURVIVAL; PANCREAS CANCER; PANCREAS SURGERY; PRIORITY JOURNAL; RISK FACTOR; SELF REPORT; SMOKING; SURVIVAL TIME; ADENOCARCINOMA; AGED; CANCER STAGING; CASE CONTROL STUDY; FAMILY HEALTH; HYPERSENSITIVITY; MIDDLE AGED; PANCREAS TUMOR; PATHOLOGY; SURVIVAL RATE; UNITED STATES;

ADENOCARCINOMA; AGED; CASE-CONTROL STUDIES; DIABETES MELLITUS; FAMILY HEALTH; FEMALE; HUMANS; HYPERSENSITIVITY; MALE; MIDDLE AGED; NEOPLASM STAGING; OBESITY; PANCREATIC NEOPLASMS; RISK FACTORS; SMOKING; SURVIVAL RATE; UNITED STATES;

EID: 78049517023     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.25240     Document Type: Article

References (59)

1. American Cancer Society. Cancer Facts and Figures 2009. Atlanta: American Cancer Society, 2009.
2. Riall TS, Nealon WH, Goodwin JS, Zhang D, Kuo Y-F, Townsend CM, Freeman JL,. Pancreatic cancer in the general population: improvements in survival over the last decade. J Gastrointest Surg 2006; 10: 1212-23; discussion 23.
3. Horner MJ, Ries LAG, Krapcho M, Neyman N, Aminou R, Howlader N, Altekruse SF, Feuer EJ, Huang L, Mariotto A, Miller BA, Lewis DR, et al. SEER cancer statistics review 1975-2006, 2009.
4. Winter JM, Cameron JL, Campbell KA, Arnold MA, Chang DC, Coleman J, Hodgin MB, Sauter PK, Hruban RH, Riall TS, Schulick RD, Choti MA, et al. 1423 pancreaticoduodenectomies for pancreatic cancer: a single-institution experience. J Gastrointest Surg 2006; 10: 1199-210; discussion 210.
5. Ansary-Moghaddam A, Huxley R, Barzi F, Lawes C, Ohkubo T, Fang X, Jee SH, Woodward M,. The effect of modifiable risk factors on pancreatic cancer mortality in populations of the Asia-Pacific region. Cancer Epidemiol Biomarkers Prev 2006; 15: 2435-40.
6. Ghadirian P, Lynch H, Krewski D,. Epidemiology of pancreatic cancer: an overview. Cancer Detect Prev 2003; 27: 87-93.
7. Lowenfels AB, Maisonneuve P,. Epidemiology and prevention of pancreatic cancer. Jpn J Clin Oncol 2004; 34: 238-44.
8. Yun JE, Jo I, Park J, Kim MT, Ryu HG, Odongua N, Kim EY, SH J,. Cigarette smoking, elevated fasting serum glucose, and risk of pancreatic cancer in Korean men. Int J Cancer 2006; 119: 208-12.
9. WCRF. Food, nutrition and the prevention of cancer: a global perspective. Washington, DC: World Cancer Research Fund/American Cancer Institute for Cancer Research, 2007.
10. Anderson KE, Mack TM, Silverman DT,. Cancer of the pancreas. In:, Schottenfeld D, Fraumeni JF, Jr, eds. Cancer Epidemiology and Prevention. New York: Oxford University Press, 2006.
11. Gapstur S, Gann PH, Lowe W, Liu K, Colangelo L, Dyer A,. Abnormal glucose metabolism and pancreatic cancer mortality. JAMA 2000; 283: 2552-8.
12. Chari ST, Leibson CL, Rabe KG, Ransom J, de Andrade M, Petersen GM,. Probability of pancreatic cancer following diabetes: a population-based study. Gastroenterology 2005; 129: 504-11.
13. Wang F, Gupta S, Holly EA,. Diabetes mellitus and pancreatic cancer in a population-based case-control study in the San Francisco Bay Area. Calif Cancer Epidemiol Biomarkers Prev 2006; 15: 1458-63.
14. Pannala R, Leibson CL, Rabe KG, Timmons LJ, Ransom J, de Andrade M, Petersen GM, Chari ST,. Temporal association of changes in fasting blood glucose and body mass index with diagnosis of pancreatic cancer. Am J Gastroenterol 2009; 104: 2318-25.
15. Fernandez E, La Vecchia C, D'Avanzo B, Negri E, Franceschi S,. Family history and the risk of liver, gallbladder, and pancreatic cancer. Cancer Epidemiol Biomarkers Prev 1994; 3: 209-12.
16. Klein AP, Hruban RH, Brune KA, Petersen GM, Goggins M,. Familial pancreatic cancer. Cancer J 2001; 7: 266-73.
17. Schenk M, Schwartz AG, O'Neal E, Kinnard M, Greenson JK, Fryzek JP, Ying GS, Garabrant DH,. Familial risk of pancreatic cancer. J Natl Cancer Inst 2001; 93: 640-4.
18. Rulyak SJ, Lowenfels AB, Maisonneuve P, Brentnall TA,. Risk factors for the development of pancreatic cancer in familial pancreatic cancer kindreds. Gastroenterology 2003; 124: 1292-9.
19. Klein AP, Brune KA, Petersen GM, Goggins M, Tersmette AC, Offerhaus GJA, Griffin C, Cameron J, Yeo CJ, Kern S, Hruban RH,. Prospective risk of pancreatic cancer in familial pancreatic cancer kindreds. Cancer Res 2004; 64: 2634-8.
20. Eppel A, Cotterchio M, Gallinger S,. Allergies are associated with reduced pancreas cancer risk: a population-based case-control study in Ontario. Can Int J Cancer 2007; 121: 2241-5.
21. Gandini S, Lowenfels AB, Jaffee EM, Armstrong TD, Maisonneuve P,. Allergies and the risk of pancreatic cancer: a meta-analysis with review of epidemiology and biological mechanisms. Cancer Epidemiol Biomarkers Prev 2005; 14: 1908-16.
22. Olson SH, Orlow I, Simon J, Tommasi D, Roy P, Bayuga S, Ludwig E, Zauber AG, Kurtz RC,. Allergies, variants in IL-4 and IL-4R alpha genes, and risk of pancreatic cancer. Cancer Detect Prev 2007; 31: 345-51.
23. Turner MC, Chen Y, Krewski D, Ghadirian P,. An overview of the association between allergy and cancer. Int J Cancer 2006; 118: 3124-32.
24. Pompei R, Lampis G, Ingianni A, Nonnis D, Ionta MT, Massidda B,. Allergy and tumour outcome after primary cancer therapy. Int Arch Allergy Immunol 2004; 133: 174-8.
25. Mack TM, Yu MC, Hanisch R, Henderson BE,. Pancreas cancer and smoking, beverage consumption, and past medical history. J Natl Cancer Inst 1986; 76: 49-60.
26. Mills PK, Beeson LW, Abbey DE, Fraser GE, Phillips R,. Dietary habits and past medical history as related to fatal pancreas cancer risk among Adventists. Cancer 1988; 61: 2578-85.
27. Farrow DC, Davis S,. Risk of pancreatic cancer in relation to medical history and the use of tobacco, alcohol and coffee. Int J Cancer 1990; 45: 816-20.
28. Jain M, Howe GR, St Louis P, Miller AB,. Coffee and alcohol as determinants of risk of pancreas cancer: a case-control study from Toronto. Int J Cancer 1991; 47: 384-9.
29. Silverman DT, Schiffman M, Everhart J, Goldstein A, Lillemoe KD, Swanson GM, Schwartz AG, Brown LM, Greenberg RS, Schoenberg JM, Pottern LM, Hoover RD, et al. Diabetes mellitus, other medical conditions and familial history of cancer as risk factors for pancreatic cancer. Br J Cancer 1999; 80: 1830-37.
30. Holly EA, Eberle CA, Bracci PM,. Prior history of allergies and pancreatic cancer in the San Francisco Bay area. Am J Epidemiol 2003; 158: 432-41.
31. Dai Q, Zheng W, Ji BT, Shu XO, Jin F, Zhu JL, Gao YT,. Prior immunity-related medical conditions and pancreatic-cancer risk in Shanghai. Int J Cancer 1995; 63: 337-40.
32. La Vecchia C, Negri E, D'Avanzo B, Ferranroni M, Gramenzi A, Savoldelli R, Boyle P, Franceschi S,. Medical history, diet and pancreatic cancer. Oncology 1990; 47: 463-66.
33. Li D, Morris JS, Liu J, Hassan MM, Day RS, Bondy ML, Abbruzzese JL,. Body mass index and risk, age of onset, and survival in patients with pancreatic cancer. JAMA 2009; 301: 2553-62.
34. McWilliams RR, Bamlet WR, Matsumoto ME, Petersen GM, Halfdanarson TR,. Correlation of high usual adult body mass index with survival in pancreatic adenocarcinoma. Gastrointestinal Cancers Symposium, San Francisco, CA, 2009.
35. Fleming JB, Gonzalez RJ, Petzel MQ, Lin E, Morris JS, Gomez H, Lee JE, Crane CH, Pisters PW, Evans DB,. Influence of obesity on cancer-related outcomes after pancreatectomy to treat pancreatic adenocarcinoma. Arch Surg 2009; 144: 216-21.
36. House MG, Fong Y, Arnaoutakis DJ, Sharma R, Winston CB, Protic M, Gonen M, Olson SH, Kurtz RC, Brennan MF, Allen PJ,. Preoperative predictors for complications after pancreaticoduodenectomy: impact of BMI and body fat distribution. J Gastrointest Surg 2008; 12: 270-8.
37. Li D, Li Y, Jiao L, Chang DZ, Beinart G, Wolff RA, Evans DB, Hassan MM, Abbruzzese JL,. Effects of base excision repair gene polymorphisms on pancreatic cancer survival. Int J Cancer 2007; 120: 1748-54.
38. Fukunaga A, Miyamoto M, Cho Y, Murakami S, Kawarada Y, Oshikiri T, Kato K, Kurokawa T, Suzuoki M, Nakakubo Y, Hiraoka K, Itoh T, et al. CD8+ tumor-infiltrating lymphocytes together with CD4+ tumor-infiltrating lymphocytes and dendritic cells improve the prognosis of patients with pancreatic adenocarcinoma. Pancreas 2004; 28: e26-31.
39. Fu SL, Pierre J, Smith-Norowitz TA, Hagler M, Bowne W, Pincus MR, Mueller CM, Zenilman ME, Bluth MH,. Immunoglobulin E antibodies from pancreatic cancer patients mediate antibody-dependent cell-mediated cytotoxicity against pancreatic cancer cells. Clin Exp Immunol 2008; 153: 401-9.
40. Gould HJ, Mackay GA, Karagiannis SN, O'Toole CM, Marsh PJ, Daniel BE, Coney LR, Zurawski VR, Jr, Joseph M, Capron M, Gilbert M, Murphy GF, et al. Comparison of IgE and IgG antibody-dependent cytotoxicity in vitro and in a SCID mouse xenograft model of ovarian carcinoma. Eur J Immunol 1999; 29: 3527-37.
41. Karagiannis SN, Wang Q, East N, Burke F, Riffard S, Bracher MG, Thompson RG, Durham SR, Schwartz LB, Balkwill FR, Gould HJ,. Activity of human monocytes in IgE antibody-dependent surveillance and killing of ovarian tumor cells. Eur J Immunol 2003; 33: 1030-40.
42. Brenner AV, Linet MS, Fine HA, Shapiro WR, Selker RG, Black PM, Inskip PD,. History of allergies and autoimmune diseases and risk of brain tumors in adults. Int J Cancer 2002; 99: 252-9.
43. Schlehofer B, Blettner M, Preston-Martin S, Niehoff D, Wahrendorf J, Arslan A, Ahlbom A, Choi WN, Giles GG, Howe GR, Little J, Menegoz F, et al. Role of medical history in brain tumour development. Results from the international adult brain tumour study. Int J Cancer 1999; 82: 155-60.
44. Schoemaker MJ, Swerdlow AJ, Hepworth SJ, McKinney PA, van Tongeren M, Muir KR,. History of allergies and risk of glioma in adults. Int J Cancer 2006; 119: 2165-72.
45. Wiemels JL, Wiencke JK, Sison JD, Miike R, McMillan A, Wrensch M,. History of allergies among adults with glioma and controls. Int J Cancer 2002; 98: 609-15.
46. Wrensch M, Wiencke JK, Wiemels J, Miike R, Patoka J, Moghadassi M, McMillan A, Kelsey KT, Aldape K, Lamborn KR, Parsa AT, Sison JD, et al. Serum IgE, tumor epidermal growth factor receptor expression, and inherited polymorphisms associated with glioma survival. Cancer Res 2006; 66: 4531-41.
47. Jensen-Jarolim E, Achatz G, Turner MC, Karagiannis S, Legrand F, Capron M, Penichet ML, Rodriguez JA, Siccardi AG, Vangelista L, Riemer AB, Gould H,. AllergoOncology: the role of IgE-mediated allergy in cancer. Allergy 2008; 63: 1255-66.
48. Liyanage UK, Moore TT, Joo HG, Tanaka Y, Herrmann V, Doherty G, Drebin JA, Strasberg SM, Eberlein TJ, Goedegebuure PS, Linehan DC,. Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma. J Immunol 2002; 169: 2756-61.
49. Wolf AM, Wolf D, Steurer M, Gastl G, Gunsilius E, Grubeck-Loebenstein B,. Increase of regulatory T cells in the peripheral blood of cancer patients. Clin Cancer Res 2003; 9: 606-12.
50. Viehl CT, Moore TT, Liyanage UK, Frey DM, Ehlers JP, Eberlein TJ, Goedegebuure PS, Linehan DC,. Depletion of CD4+CD25+ regulatory T cells promotes a tumor-specific immune response in pancreas cancer-bearing mice. Ann Surg Oncol 2006; 13: 1252-8.
51. Clark CE, Hingorani SR, Mick R, Combs C, Tuveson DA, Vonderheide RH,. Dynamics of the immune reaction to pancreatic cancer from inception to invasion. Cancer Res 2007; 67: 9518-27.
52. Ademmer K, Ebert M, Muller-Ostermeyer F, Friess H, Buchler MW, Schubert W, Malfertheiner P,. Effector T lymphocyte subsets in human pancreatic cancer: detection of CD8+CD18+ cells and CD8+CD103+ cells by multi-epitope imaging. Clin Exp Immunol 1998; 112: 21-6.
53. von Bernstorff W, Voss M, Freichel S, Schmid A, Vogel I, Johnk C, Henne-Bruns D, Kremer B, Kalthoff H,. Systemic and local immunosuppression in pancreatic cancer patients. Clin Cancer Res 2001; 7: 925s-32s.
54. Arbes SJ, Jr, Gergen PJ, Elliott L, Zeldin DC,. Prevalences of positive skin test responses to 10 common allergens in the US population: results from the third National Health and Nutrition Examination Survey. J Allergy Clin Immunol 2005; 116: 377-83.
55. Law M, Morris JK, Wald N, Luczynska C, Burney P,. Changes in atopy over a quarter of a century, based on cross sectional data at three time periods. BMJ 2005; 330: 1187-8.
56. Linneberg A, Nielsen NH, Madsen F, Frolund L, Dirksen A, Jorgensen T,. Increasing prevalence of specific IgE to aeroallergens in an adult population: two cross-sectional surveys 8 years apart: the Copenhagen Allergy Study. J Allergy Clin Immunol 2000; 106: 247-52.
57. Linneberg A, Nielsen NH, Madsen F, Frolund L, Dirksen A, Jorgensen T,. Smoking and the development of allergic sensitization to aeroallergens in adults: a prospective population-based study. The Copenhagen Allergy Study. Allergy 2001; 56: 328-32.
58. Verlato G, Corsico A, Villani S, Cerveri I, Migliore E, Accordini S, Carolei A, Piccioni P, Bugiani M, Lo Cascio V, Marinoni A, Poli A, et al. Is the prevalence of adult asthma and allergic rhinitis still increasing? Results of an Italian study. J Allergy Clin Immunol 2003; 111: 1232-8.
59. Latvala J, von Hertzen L, Lindholm H, Haahtela T,. Trends in prevalence of asthma and allergy in Finnish young men: nationwide study, 1966-2003. BMJ 2005; 330: 1186-7.